EUVIMEDEUVIMED entdecken
Crossref

Frequency and Genotype‐Dependence of intrinsic chronotropic insufficiency among patients with congenital long QT syndrome

Veda K Kulkarni, Alexa M Pinsky, J Martijn Bos iD, Raquel Neves, Sahej Bains iD, John R Giudicessi iD, Thomas G Allison, Michael J Ackerman iD

Journal of Cardiovascular Electrophysiology · 2025

DOI: 10.1111/jce.16471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Veda K Kulkarni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, Minn…. Hauptthemen laut MEDLINE: Long QT Syndrome, Heart Rate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long QT syndrome (LQTS) is a cardiac channelopathy characterized by QT prolongation and a potential for arrhythmic syncope, sudden cardiac arrest or deaths (SCA/SCD). It has been speculated that patients with LQTS might have a primary sinoatrial node (SAN) phenotype of chronotropic insufficiency (CI). This has not been demonstrated convincingly before because of the potentially confounding effects of beta blocker (BB) therapy. Herein, we set out to determine whether untreated patients with LQTS demonstrate intrinsic CI. Methods and Results A retrospective review of all treadmill exercise stress tests (TEST) was performed on patients with one of the three most common LQTS genotypes: LQT1, LQT2, and LQT3. For each patient, the first TEST completed while off BB was analyzed. Patients with prior left cardiac sympathetic denervation (LCSD) therapy were excluded. CI was defined as having an age‐ and gender‐predicted peak heart rate (HR) < 85% and/or a predicted HR reserve (HRR) < 80%. Overall, 463 LQTS patients (245 LQT1, 125 LQT2, and 93 LQT3) were included (267 female [58%]; mean age at time of TEST [29 ± 17 years]). Mean % predicted peak HR for all LQTS patients was 87.6% (range 42.9% ‐ 119.1%) and mean % predicted HRR was 80% (range 19.1% ‐ 153%). Overall, half of all LQTS patients (n = 234; 51%) displayed CI; 64% of patients with LQT1 (n = 157), 37% with LQT2 (n = 46), and 33% with LQT3 (n = 31). Patients with LQT1 were most likely to exhibit CI compared to patients with LQT2 ( p < .0001) and LQT3 ( p < .0001). CI was significantly more common in LQT1 compared to controls ( p < .0001), while there was no difference between LQT2 ( p = .5) or LQT3 and controls ( p > .9). Presence of CI was not a predictor of LQTS‐associated symptoms, BB side effects or likelihood of future breakthrough cardiac events (BCE).

Conclusions

Patients with LQTS, particularly LQT1, demonstrate a SAN phenotype of CI. If assessing BB therapy effect by impact on peak HR, the patient's pretreatment peak HR, rather than an age‐ and gender‐predicted maximum HR, should be used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Long QT SyndromeHeart RateHumansFemaleMaleRetrospective StudiesAdultPhenotypeYoung AdultMiddle AgedAdolescentExercise TestGenetic Predisposition to DiseaseGenotypeRisk FactorsChild

Stichwörter der Autor:innen

beta blockerschronotropic insufficiencyexercise stress testingheart rate reservelong QT syndrome

Autor:innen und Institutionen

  • Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, Minnesota.
  • Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic, Rochester, MN, USA.
  • Department of Cardiovascular Medicine, Division of Heart Rhythm Services (Windland Smith Rice Genetic Heart Rhythm Clinic), Mayo Clinic, Rochester, Minnesota.
  • Medical Scientist Training Program, Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota.

ORCID-Profile: J Martijn Bos, Sahej Bains, John R Giudicessi, Michael J Ackerman

Förderung

  • NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Kulkarni, V. K., Pinsky, A. M., Bos, J. M., Neves, R., Bains, S., Giudicessi, J. R., Allison, T. G., & Ackerman, M. J. (2025). Frequency and Genotype‐Dependence of intrinsic chronotropic insufficiency among patients with congenital long QT syndrome. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16471

Vancouver

Kulkarni VK, Pinsky AM, Bos JM, Neves R, Bains S, Giudicessi JR, et al. Frequency and Genotype‐Dependence of intrinsic chronotropic insufficiency among patients with congenital long QT syndrome. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16471

BibTeX
@article{Kulkarni2025,
  author = {Kulkarni, Veda K and Pinsky, Alexa M and Bos, J Martijn and Neves, Raquel and Bains, Sahej and Giudicessi, John R and Allison, Thomas G and Ackerman, Michael J},
  title = {Frequency and Genotype‐Dependence of intrinsic chronotropic insufficiency among patients with congenital long QT syndrome},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  doi = {10.1111/jce.16471}
}
Kostenlos starten →